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Abstract
The emerging field of precision oncology relies on the accurate pinpointing of
alterations in the molecular profile of a tumor to provide personalized targeted
treatments. Current methodologies in the field commonly include the application
of next generation sequencing technologies to a tumor sample, followed by the
identification of mutations in the DNA known as somatic variants. The differ-
entiation of these variants from sequencing error poses a classic classification
problem, which has traditionally been approached with Bayesian statistics, and
more recently with supervised machine learning methods such as neural networks.
Although these methods provide greater accuracy, classic neural networks lack
the ability to indicate the confidence of a variant call. In this paper, we explore
the performance of deep Bayesian neural networks on next generation sequencing
data, and their ability to give probability estimates for somatic variant calls. In
addition to demonstrating similar performance in comparison to standard neural
networks, we show that the resultant output probabilities make these better suited
to the disparate and highly-variable sequencing data-sets these models are likely
to encounter in the real world. We aim to deliver algorithms to oncologists for
which model certainty better reflects accuracy, for improved clinical application.
By moving away from point estimates to reliable confidence intervals, we expect
the resultant clinical and treatment decisions to be more robust and more informed
by the underlying reality of the tumor molecular profile.
1 Introduction
Cancer is a disease of the genome, in which a range of structural genomic changes to the DNA of
otherwise healthy cells, results in a cancer phenotype. A well-studied subset of these aberrations
is single nucleotide variants and short insertion/deletion mutations. Identification of these through
next generation sequencing for a given individual can now be commonly used in clinical practice to
provide targeted and personalized therapies; a field known as precision oncology [1]. However, the de-
convolution of these somatic variants from sequencing error provides a somatic/artifact classification
problem which is yet to be fully resolved.
This problem has been traditionally approached with Bayesian classifiers [2, 3], which give reasonable
accuracy whilst providing information on the robustness of the variant call. More recently, there have
been attempts to increase the accuracy of variant calls through neural network-based approaches,
such as DeepVariant (germline variants)[4] and SomaticNET[5, 6] (somatic variants). However, these
are yet to provide the advantage of output probabilities that better represents the underlying reality of
the tumor.
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In this study, we aim to build upon our previous work in applying Bayesian Neural Networks (BNNs)
to somatic variant calling [7], an approach which enables the network to learn a posterior probability
density function (pdf) over the spaceW of the weights, and in turn provide a measure of uncertainty
which makes the model more robust. We build on this by investigating the distribution of output
probabilities compared to standard neural networks, when applied to real-world data and in various
out-of-distribution scenarios commonly observed in disparate sequencing data-sets.
2 Variant Calling
The task, data & labels for this study are consistent with our previous work in this field[7] as follows:
2.1 The Task
Next generation DNA sequencing techniques produce overlapping short sequences of DNA called
reads. For a fixed position in a sequenced genome, we observe a number of reads originating from
multiple cells. We call this number the depth. When, for a given patient, we sequence both tumor
and normal tissues for comparison, we expect to see a number of true somatic variants (in the tumor
tissue but not in the normal tissue), although the vast majority of the variations observed are due to
sequencing noise. The task we undertake here involves the differentiation of somatic variants (tumor)
from germline variants (normal) and sequencing error (noise) .
2.2 The Data
We developed a bioinformatics pipeline to identify genomic loci where sequencing data from the
tumor significantly differs from the normal. We extract the data in the following form:
pair =
 N11 . . . N1w T11 . . . T1w... . . . ... ... . . . ...
Nd1 . . . Ndw Td1 . . . Tdw

d : the depth
w : the width or number of observed loci
Nij : The normal base at position i and depth d
Tij : The tumor base at position i and depth d Figure 1: A visual representation of the pair ma-
trix with w = 10 and d = 100
2.3 The Labels
For Training, we used the Multi-Center Mutation Calling in Multiple Cancers (MC3) high confidence
variant dataset [8]. The labels for this dataset are binary: 1 if the variant is validated positive, 0 if the
variant is validated negative. We did not include non-validated data.
The input data is the aforementioned pair matrices with a specific size of (100, 20) with three color
channels. We reshape the input data from (100, 20, 3) to (100, 60), diluting the color information to
analyze using LSTMs. Secondly, we balanced the dataset by undersampling the majority class. This
resulted in a total of 103,868 (image, label) pairs. For these data we used a 0.8 training-test split.
3 Methods
We start from the Bayesian Neural Network architecture demonstrated in Figure 3, implemented
using Tensorflow and the Tensorflow Probability library. To test its robustness and performance we
compare it with a standard neural network, identical with the exception of substituting the variational
layer DenseFlipout with a Dense layer.
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Figure 2: Architecture of the network
These methods build on much of our previous work on a suitable cost function for this type of data
and this classification problem[7].
We use variational layers during training with data D, to learn an approximate probability density
function Q~w(~θ) of the true, usually intractable, posterior p(~w|D) for the weights of the network. This
formally should be done by minimizing the KL divergence between the two. Minimizing this KL
divergence is equivalent to minimizing another cost function, known as -ELBO (Evidence Lower
Bound)[9]
−ELBO = −EQ~w(~θ)log(P (D|~w)) +KL(Q~w(~θ)||p(~w)) (1)
where P (D|~w) and p(~w) are the likelihood of the data and the prior respectively for the weights ~w,
and Q~w(~θ) is an approximate pdf to the true posterior.
Practically, as the integrals in 1 are in general analytically intractable, they are computed via Monte
Carlo (MC) sampling from the approximate pdf Q~w(~θ). This is automatically done by the variational
layers in tfp.
Secondly, as it is costly to calculate the ELBO for large datasets such as those in DNA sequencing,
tfp allows to do minibatch optimization. Therefore, 1 is calculated as an average over many ELBOs
calculated on batches of data Dk with sampled weights ~wi
ˆELBO =
1
NMC,elbo
NMC,elbo∑
i=1
[−(log(p(~wi)) + log(p(Dk)|~wi))) + log(q(~wi)|~θ)] (2)
This approximation is an unbiased stochastic estimator for the ELBO[9]. As a result, the calculated
gradient will not be miscalculated, allowing convergence to the correct solution.
Flipout estimator [10] provides the unbiased ELBO estimation with lower variance than other methods
(although larger numerical cost). This is well appreciated, since the optimization of ELBO depends
largely on its variance.
Once the pdf Q~w(~θ) ∼ p(~w|D) is fitted by minimizing -ELBO, one can infer y∗ with test datum X∗,
by computing:
p(y∗) =
∫
d~wp(y∗|X∗, ~w)p(~w|D) (3)
In practice, this is done by Monte Carlo sampling. We substitute the integral with an averaged sum
over the weights sampled from the approximate posterior, then we take the average.
pˆ(y∗) =
1
NMC
∑
~wk∼Q~w(~θ)
p(y∗|X∗, ~wk) (4)
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In a classification problem, this means that for each possible outcome y∗ ∈ A, where A is the set of
all outcomes, we will calculate this estimate pˆ(y∗), ensuring that
∑
y∗∈A pˆ(y
∗) = 1.
As we will show later, the nice property of this implementation of a BNN, is that it becomes more
uncertain to out of distribution samples with respect to the standard network.
As it is known, in particular for very deep one, standard neural networks suffer from uncalibration of
the probability that comes from the logits. A way to overcome partially this is temperature scaling
[11].
We applied temperature scaling [11] calibration on the standard network in order to make the
comparison more fair. Temperature scaling consists of minimizing the cross-entropy, after the
network is trained, by fitting a new parameter T with validation data, defined as follows:
yˆ =
elogitsi/T∑
logitsj/T
(5)
In order to evaluate the calibration of a network we use Expected Calibration Error (ECE) [11], the
results of which are displayed in Figure 3. This is done by sorting the predictions and partitioning them
in K bins. We compute, per bin, the absolute difference between the accuracy and the confidence,
weighted by the bin probability.
ECE =
K∑
i=1
|Bi|
n
·
∣∣∣∣∣
∑
Yˆi = Yi
|Bi| − Pi
∣∣∣∣∣ (6)
where Bi is the ith bin, n the number of examples, Yi, Yˆi, Ci the label, prediction and confidence
vector for bin i.
Figure 3: Average accuracy per confidence bin and expected calibration error (ECE)
4 Results
The two models have a similar accuracy (Variational: 80% - Dense: 81%), although we observe a
large difference in their output distributions. The variational inference outputs greater density around
0.5 than the standard network. A similar output is achieved with temperature scaling (Figure 4).
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Figure 4: Output distributions for different models. The left-most panel displays one input pair
matrix. Then, from left to right, outputs are shown for the Variational Dense + ELBO, the Dense +
Cross-entropy, and the Dense + Cross-entropy with temperature scaling, respectively.
Intuitively, if the distribution of the testing data is too different from the distribution of the training
data (e.g. batch variation, such as samples with a different distribution of sequencing error), we expect
the confidence of the model to decrease accordingly. Such a behavior is not observed in common
neural networks. To show this, we generated out-of-distribution testing data by adding Gaussian
noise to the pair input. We can observe (Figure 5) that the standard neural network is over-confident,
whereas the variational approach shows a greater tendency to reduce the overall scatter between
positive and negative predictions than the classic approach.
Figure 5: The same output distributions, for data with Gaussian noise added. The left-most panel
displays an example pair matrix with Gaussian noise.
Similarly, differing sequencing depth is another commonly-occurring example of sample variability.
If the network is used in a clinical setting on data with significantly lower depth than the training data,
it is important for the confidence to be proportionally lowered. This is reflected in the variational
model (Figure 6), with modes closer to 0.5 and a smaller variance than standard neural networks.
Figure 6: The same distributions of output probabilities, for limited data. The left-most panel displays
an example pair matrix with reduced sequencing depth.
Overall, these results suggest that the variational model is best suited to disparate and highly-variable
genomic sequencing data-sets, providing output probabilities that reflect the test data well.
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5 Conclusion
We have shown in this paper that, for the application of somatic variant calling in cancer, not only can
BNNs be utilized instead of standard neural networks without significant performance degradation,
but also for obtaining more representative probability values for calls. Specifically, in regions where
data is sparse or out-of-distribution, the network becomes uncertain and reflects this well in the
output scatter. This does not occur in standard NNs, where the network outputs values of high
confidence regardless of out-of-distribution scenarios. We aim to deploy these models to enable
flexible but robust molecular profiling of tumors, for superior application of targeted therapies in
precision oncology.
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